We are live on
!
Find out more
Verrica Pharmaceuticals
VRCA
VRCA
51 hedge funds and large institutions have $72.1M invested in Verrica Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
13% more funds holding
Funds holding: 45 → 51 (+6)
0.02% less ownership
Funds ownership: 3.25% → 3.23% (-0.02%)
12% less capital invested
Capital invested by funds: $82M → $72.1M (-$9.93M)
50% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 18
Holders
51
Holders Change
+6
Holders Change %
+13.33%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
9
Reduced
18
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$244K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$226K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$202K |
| 4 |
Truist Financial
Charlotte,
North Carolina
|
+$93.1K |
| 5 |
Goldman Sachs
New York
|
+$89K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1.07M |
| 2 |
JP Morgan Chase
New York
|
-$125K |
| 3 |
BlackRock
New York
|
-$121K |
| 4 |
Barclays
London,
United Kingdom
|
-$113K |
| 5 |
PP
PDT Partners
New York
|
-$99K |
